author-photo

J.F.R. Robertson

Nottingham City Hospital

150

Papers

19196

Citations

Citation Trend

Filter By

Papers (113) Sort By

Journal Conference Others

Abstract P2-12-01: Dose- and exposure-response relationship and biomarker correlation analysis in breast tumors from patients treated with capivasertib, an AKT inhibitor, in the STAKT randomized, placebo controlled pre-surgical study

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P4-13-11: Meta-analyses of visceral versus non-visceral metastases treated by SERM, AI & SERD agents as 1st line endocrine therapy (ET) for HR+ breast cancer (BC)

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P2-03-02: Markers of PI3K/Akt, ER & AR pathways and Ki67 expression in relation to tamoxifen outcome in ER+ breast cancer

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract GS1-03: Peri-operative aromatase inhibitor treatment in determining or predicting longterm outcome in early breast cancer – The POETIC* Trial (CRUK/07/015)

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (14)
Abstract P4-04-06: AZD5363, an AKT inhibitor, significantly inhibits key biomarkers of the AKT pathway and Ki67, in a randomized, placebo, controlled study (STAKT) in human breast cancers

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD5-05: Genomic instability and poor antiproliferative response to aromatase inhibitor treatment: A POETIC study

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P2-09-02: True effect of aromatase inhibitor (AI) treatment on global gene expression (expr) changes in postmenopausal ER+ breast cancer (BC) patients: A POETIC study (CRUK/07/015)

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract P2-10-02: The impact of intrinsic subtypes and molecular features on aromatase inhibitor induced reduction of proliferation marker of Ki67 in primary ER+ breast cancer: A POETIC study (CRUK/07/015)

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P2-05-01: Clinico-pathological relationships with Ki67 in POETIC (CRUK/07/015) – Critical lessons for assessing Ki67 for prognosis and as a pharmacodynamic marker

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
Abstract P2-08-02: Progression-free survival results in patient subgroups from a Phase 3 randomized trial of fulvestrant 500 mg vs anastrozole for hormone receptor-positive advanced breast cancer (FALCON)

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)